Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate CancerNCT05005728XNCRPhase 2Completed2025-06-10Actual
Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the KneeNCT05008835ACADPhase 2Terminated2022-10-06Actual
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2NCT05011396VTGNPhase 3Terminated2022-08-16Actual
Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine PreventionNCT05016661AEONPhase 2Terminated2024-07-31Actual
Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)NCT05018416ProkidneyPhase 2Completed2025-05-20Actual
Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis TreatmentNCT05021536AMLXPhase 3Unknown2024-01-19Actual
A Clinical Trial of PRAX-944 in Participants With Essential TremorNCT05021978Praxis Precision MedicinesPhase 2Completed2022-03-24Actual
A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential TremorNCT05021991Praxis Precision MedicinesPhase 2Completed2023-02-09Actual
An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular MelanomaNCT05022901DCTHPhase 3Active not recruiting2024-03-01Estimated
NEO100 and High-Grade MeningiomaNCT05023018Neonc Technologies, Inc.Phase 2Recruiting2026-12-30Estimated
Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)NCT05028582ARQTPhase 3Completed2022-06-03Actual
Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)NCT05030350VTGNPhase 3Terminated2022-09-23Actual
A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)NCT05031780AGIOPhase 2, Phase 3Active not recruiting2025-10-30Actual
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary MalignanciesNCT05032040XNCRPhase 2Active not recruiting2025-10-15Estimated
A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic GlaucomaNCT05042609Tarsier PharmaPhase 3Completed2023-06-29Actual
ITIL-168 in Advanced MelanomaNCT05050006Instil BioPhase 2Terminated2023-02-27Actual
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary CholangitisNCT05050136MIRMPhase 2Active not recruiting2027-01Estimated
Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic MalformationsNCT05050149PVLAPhase 2Completed2022-11-15Actual
A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALSNCT05053035ALECPhase 2Terminated2022-10-28Actual
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple SclerosisNCT05054140Immunic AGPhase 2Unknown2025-01-07Estimated
Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AMLNCT05054543APLMPhase 3Terminated2024-08-22Actual
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard TherapiesNCT05054725RVMDPhase 2Completed2024-07-03Actual
A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With NarcolepsyNCT05059223AXSMPhase 3Completed2024-03-15Actual
The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye DiseaseNCT05062330ALDXPhase 3Completed2022-03-04Actual
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)NCT05065216DMACPhase 2, Phase 3Recruiting2026-12Estimated
Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast CancerNCT05065411VERUPhase 3Terminated2023-10-19Actual
A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)NCT05066230KODPhase 3Terminated2023-08-03Actual
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)NCT05066997OculisPhase 2, Phase 3Completed2026-04-10Actual
A Ph 2 Trial With an Oral Tableted COVID-19 VaccineNCT05067933VaxartPhase 2Terminated2022-06-10Actual
Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast DensityNCT05068388ATOSPhase 2Completed2024-06-14Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.